Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development Overview
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEW
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEW
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEW
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREOur mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORECareers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE
"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSUnravel the complexities of cancer treatment with patient-level data-driven solutions.
Our mission is to advance the fight against cancer by providing real-world clinical insights and data-driven solutions to Life Sciences companies, cancer researchers, and healthcare professionals.
IQVIA delivers oncology data assets from a stable and representative panel of physicians to give you a competitive edge in the rapidly evolving oncology landscape.
IQVIA Global Oncology Intelligence provides you with the latest insights on cancer treatments, market dynamics, and clinical practice to make informed decisions.
Access harmonized data and treatment insights to understand global trends in cancer care and stay ahead of the competition.
Join us as we explore the evolving landscape of precision medicine and biomarker testing and its impact on oncology markets across different tumor types and geographies.
Wednesday, July 10, 2024
Join IQVIA in its Launch Excellence web-series where we share key trends impacting oncology launches, explore factors driving successful commercial models for new oncology launches, and share learnings from an industry expert.
Wednesday, June 19, 2024
Explore IQVIA experts research, as discussed at ASCO 2024: Usage pattern of anticoagulants in oncology patients receiving active anticancer therapies in Europe and Asia.
We now have new treatments for patients suffering from a type of blood cancer called acute myeloid leukemia (acronym AML). They are available as the first choice of therapy. In this study we explored how these new treatments are included in daily patient care.
Explore the evolving landscape of biomarkers and their impact on oncology markets across different tumor types and geographies.
Explore the latest CAR T-Cell therapy market developments, learn how to best prepare for future economic challenges, and discover how CAR T-Cell data assets can be leveraged to address future market fluctuations
Discover proven strategies and insights refined over more than 5,000 launches around the world.
Discover actionable brand insights at the intersection of market research and advanced analytics.
Be proactive about growing your brand using the latest in data, analytics, and domain expertise.
Flexible solutions. Responsive teams. Data-driven insights.
Change the model of clinical research by integrating data, expertise, analytics and technology from study design through execution to power better decisions.
Access a dedicated network of European cancer hospitals to capture real world data that reflects the latest clinical practice and perform oncology studies faster.
Focus oncology development on the patient, manage trial complexity, and increase predictability and speed.
